Physician Assistant Exam Review

  • About
  • Contact
  • Blueprint
  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails
  • For PA Programs
You are here: Home / Podcasts / S2 E078 Leukemia

S2 E078 Leukemia

https://traffic.libsyn.com/secure/physicianassistantexamreview/S2_E078_Leukemia.mp3

Podcast: Play in new window | Download

Leukemia

  • Leukemia is a disease characterized by the overproduction of a particular type of blood cell.
  • This process often inhibits the production of normal blood cells
  • These leukemia cells do not function as proper cells
  • Leukemia does not form a solid tumor. Rather it produces blood cells which may infiltrate tissue.
  • Leukemic cells have unusually long lives and avoid preprogramed cell death or apoptosis
  • Swollen lymph glands and an enlarged spleen are often seen due to collecting WBC’s
  • Acute leukemia is when the overproduction occurs rapidly and there is a fast increase in the number of WBCs. These cells tend to be immature blasts.
  • Chronic Leukemia is the slower build up of mature but abnormal and non-functioning WBCs.
  • The type of leukemia depends on the specific type of cell being produced.
  • Multipotential hematopoietic stem cells produce either myeloid progenitor cells or lymphoid progenitor cells
    • Lymphoid progenitor cells produce
      • B lymphocytes
      • Plasma cells
      • T lymphocytes
      • Natural killer cells
    • Myeloid progenitor cells produce
      • Megakaryocytes
      • Thrombocytes
      • Erythrocytes
      • Mast cells
      • Myeloblasts
      • Basophils
      • Neutrophils
      • Eosinophils
      • Macrophages
  • Lymphocytic leukemia is characterized by the overproduction of lymphocytes
  • Myelogenous leukemia is characterized by the overproduction of red blood cells as well as some white blood cells and platelets
  • You can then pair the two cell types of with the two time frames
  • Acute lymphocytic leukemia (ALL)
  • Chronic lymphocytic leukemia (CLL)
  • Acute myelogenous leukemia (AML)
  • Chronic myelogenous leukemia (CML)
Leukemia

Acute lymphocytic leukemia (ALL)

  • Excessive lymphoblasts
  • Abnormal cells produced have unusually long lives
  • These leukemia cells have the ability to infiltrate organs and the Central Nervous System
  • Most commonly found between the ages of 2 & 5 but can effect any age group
  • This is the most common form of leukemia in children
  • Overcrowding of the bone marrow is the main issue

Clinical Presentation

  • Anemia
    • Weakness
    • Fatigue
    • Tachycardia
  • Thrombocytopenia
    • Petechia
    • Epistaxis
    • Bleeding gums
  • Organ infiltration
    • Bone and joint pain
    • Enlarged lymph nodes and liver
    • Headaches
    • Visual and audio disturbances
  • Infections / Fever

Labs & Studies & Physical Exam Findings

  • Enlarged lymph nodes
  • CBC
    • Elevated white blood cell count
    • Pancytopenia
  • Peripheral blood smear
    • Elevated blasts
    • Pancytopenia with circulating blasts
  • Bone marrow biopsy with elevated blast cells
  • Cytogenetics – Looking for B and T lymphocytes
  • Cytogenetics, cytochemical stains and flow cytometry are used to determine subtypes and distinguish AML from ALL
  • CT or ultrasound may be used to determine organ infiltration

Treatment

  • Supportive care
    • Deal promptly with infections
    • Maintain good hydration
    • Transfusions
  • Chemotherapy
  • Steroids and methotrexate
  • Bone marrow transplant
  • Survival rates range from 20-75% depending on the characteristics and subtype of disease

Chronic Lymphocytic Leukemia (CLL)

  • Chronic lymphocytic leukemia is also known as B cell leukemia because it is usually monoclonal malignant B cells
  • The most common type of leukemia
  • Most commonly diagnosed in men over 50 years old

Clinical Presentation

  • Routine physical exam – most patients are asymptomatic early in the disease process
  • Vague symptoms
    • Fatigue
    • Weakness
    • Weight loss
    • Night sweats

Labs, Studies and Physical Exam Findings

  • Lymphadenopathy
  • Splenomegaly
  • Hepatomegaly
  • CBC with with WBCs greater than 20,000 and lymphocytes greater than 5,000
  • Flow cytometry can be used to test for monoclonal B cells
  • Bone marrow biopsy showing small lymphocytes
  • Lymph Node biopsy

Treatment

  • Supportive care
    • Deal promptly with infections
    • Maintain good hydration
  • Transfusions
  • Chemotherapy
  • Radiation
  • Bone marrow transplant
  • Splenectomy
  • Prognosis is between 2 and 20 years depending on subtype

Acute Myelogenous Leukemia (AML)

  • AML is more often seen in adults

Clinical Presentation

  • Anemia
    • Weakness
    • Fatigue
    • Tachycardia
  • Thrombocytopenia
    • Petechia
    • Epistaxis
    • Bleeding gums
  • Organ infiltration (less frequent than ALL)
    • Bone and joint pain
    • Enlarged lymph nodes and liver
    • Headaches
    • Visual and audio disturbances

Labs, studies and Physical Exam Findings

  • Enlarged lymph nodes are rare
  • CBC
    • Elevated white blood cell count
    • Pancytopenia
  • Peripheral blood smear
    • Elevated blasts (may make up to 90% of WBCs)
    • Pancytopenia
  • Bone marrow biopsy with elevated blast cells
  • Peripheral blood smear
    • Auer rods are pathognomonic for AML
  • Cytogenetics, cytochemical stains and flow cytometry are used to determine subtypes and distinguish AML from ALL

Treatment

  • Supportive care
    • Deal promptly with infections
    • Maintain good hydration
  • Transfusions
  • Chemotherapy
  • Stem cell transplant

Chronic myelogenous leukemia (CML)

  • Mean age of diagnosis is 65 years old
  • An abnormal pluripotent hematopoietic progenitor cell starts reproducing
  • Unregulated growth of many different types of cells are possible
    • Red Blood Cells
    • Neutrophils
    • Eosinophils
    • Basophils
    • Megakaryocytes
    • etc
  • Three phases
    • Chronic
      • Stable period last about five years
    • Accelerated
      • Symptoms become difficult to treat
    • Blast
      • Similar to acute leukemia with an overwhelming number of blasts
  • The Philadelphia Chromosome is present in almost all cases
  • CML will end in blast phase which is much like an acute leukemia

Clinical Presentation

  • Most patients are asymptomatic and in the Chronic phase
  • As a patient enters the accelerated phase vague symptoms begin to appear
    • Fatigue
    • Weakness
    • Abdominal fullness
    • Weight loss
    • Night sweats
    • Splenomegaly
      • Enlarged spleen may cause left upper quadrant pain or loss of appetite
  • Enlarged lymph nodes
  • Bleeding and bruising
  • Pallor
  • Shortness of breath

Labs, studies and physical exam findings

  • CBC with WBC’s as high as 150,000 with elevated granulocytes
    • neutrophils
    • eosinophils
    • basophils
  • Peripheral blood smear
  • Bone marrow biopsy – Philadelphia Chromosome is pathognomonic for CML

Treatment

  • Bone marrow transplant or stem cell transplant may be curative
  • Tyrosine kinase inhibitors
  • Myelosuppressive therapy
  • Splenectomy
  • Median survival had been between 3 & 5 years. With tyrosine kinase inhibitors and other medical treatment 7-10 years is more normal today.

Key terms and ideas

  • Acute lymphocytic leukemia (ALL)
    • Found in kids 2-5
    • Lots of circulating blasts
  • Chronic lymphocytic leukemia (CLL)
    • Patients are usually men over 50
    • Patients typically have no symptoms
  • Acute myelogenous leukemia (AML)
    • Found in adults
    • Pancytopenia with circulating blasts
    • Auer rods are pathognomonic for AML
  • Chronic myelogenous leukemia (CML)
    • Found in adults
    • Most patients are asymptomatic at diagnosis
    • Radiation exposure is a risk factor
    • Philadelphia Chromosome is pathognomonic for CML
  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails
  • For PA Programs

logo Privacy Policy | Fulfillment Policy | Terms of Service | Web design by OptimWise

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

Loading Comments...